Antibody-mediated injury in the renal allograft

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Antibody-mediated renal allograft injury can give rise to a range of histological and ultrastructural changes, with or without C4d deposition. The changes associated with alloantibody can be seen on surveillance biopsies in patients with normal graft function or on clinically indicated biopsies. In this case report, we review a series of biopsies at different time points, from 1 month to 2 years after transplantation, from a single kidney allograft in a patient who had donor-specific alloantibody (DSA) before transplantation. In the early posttransplant period, the patient was at risk for acute humoral rejection, with high serum DSA levels and C4d deposition in the graft, but acute humoral rejection was averted by early use of a C5 inhibitor drug. Later, while maintaining stable graft function, the patient developed the following biopsy features of chronic antibody-mediated injury: peritubular capillaritis, peritubular capillaropathy (peritubular capillary basement membrane multilamination) seen by electron microscopy, and early transplant glomerulopathy, along with activated endothelial cells detected by electron microscopy. Late biopsies did not show C4d deposition, and the patient had low serum DSA levels, raising the possibility that noncomplement-mediated pathways may be involved in late antibody-mediated allograft injury. The pathologist can recognize changes attributable to alloantibody and distinguish these features from T-cell-mediated rejection, which will allow for appropriate treatment of these patients.

Original languageEnglish (US)
Pages (from-to)219-224
Number of pages6
JournalPathology Case Reviews
Volume17
Issue number6
DOIs
StatePublished - Nov 2012

Fingerprint

Isoantibodies
Allografts
Kidney
Antibodies
Wounds and Injuries
Biopsy
Transplants
Tissue Donors
Electron Microscopy
Transplantation
Serum
Basement Membrane
Endothelial Cells
T-Lymphocytes
Pharmaceutical Preparations

Keywords

  • eculizumab
  • kidney
  • peritubular capillary
  • sensitized
  • transplant

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Antibody-mediated injury in the renal allograft. / Cornell, Lynn D.; Alexander, Mariam P; Stegall, Mark D.

In: Pathology Case Reviews, Vol. 17, No. 6, 11.2012, p. 219-224.

Research output: Contribution to journalArticle

@article{e0327430f4d640abb8133794fe0f9723,
title = "Antibody-mediated injury in the renal allograft",
abstract = "Antibody-mediated renal allograft injury can give rise to a range of histological and ultrastructural changes, with or without C4d deposition. The changes associated with alloantibody can be seen on surveillance biopsies in patients with normal graft function or on clinically indicated biopsies. In this case report, we review a series of biopsies at different time points, from 1 month to 2 years after transplantation, from a single kidney allograft in a patient who had donor-specific alloantibody (DSA) before transplantation. In the early posttransplant period, the patient was at risk for acute humoral rejection, with high serum DSA levels and C4d deposition in the graft, but acute humoral rejection was averted by early use of a C5 inhibitor drug. Later, while maintaining stable graft function, the patient developed the following biopsy features of chronic antibody-mediated injury: peritubular capillaritis, peritubular capillaropathy (peritubular capillary basement membrane multilamination) seen by electron microscopy, and early transplant glomerulopathy, along with activated endothelial cells detected by electron microscopy. Late biopsies did not show C4d deposition, and the patient had low serum DSA levels, raising the possibility that noncomplement-mediated pathways may be involved in late antibody-mediated allograft injury. The pathologist can recognize changes attributable to alloantibody and distinguish these features from T-cell-mediated rejection, which will allow for appropriate treatment of these patients.",
keywords = "eculizumab, kidney, peritubular capillary, sensitized, transplant",
author = "Cornell, {Lynn D.} and Alexander, {Mariam P} and Stegall, {Mark D}",
year = "2012",
month = "11",
doi = "10.1097/PCR.0b013e3182759333",
language = "English (US)",
volume = "17",
pages = "219--224",
journal = "Pathology Case Reviews",
issn = "1082-9784",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Antibody-mediated injury in the renal allograft

AU - Cornell, Lynn D.

AU - Alexander, Mariam P

AU - Stegall, Mark D

PY - 2012/11

Y1 - 2012/11

N2 - Antibody-mediated renal allograft injury can give rise to a range of histological and ultrastructural changes, with or without C4d deposition. The changes associated with alloantibody can be seen on surveillance biopsies in patients with normal graft function or on clinically indicated biopsies. In this case report, we review a series of biopsies at different time points, from 1 month to 2 years after transplantation, from a single kidney allograft in a patient who had donor-specific alloantibody (DSA) before transplantation. In the early posttransplant period, the patient was at risk for acute humoral rejection, with high serum DSA levels and C4d deposition in the graft, but acute humoral rejection was averted by early use of a C5 inhibitor drug. Later, while maintaining stable graft function, the patient developed the following biopsy features of chronic antibody-mediated injury: peritubular capillaritis, peritubular capillaropathy (peritubular capillary basement membrane multilamination) seen by electron microscopy, and early transplant glomerulopathy, along with activated endothelial cells detected by electron microscopy. Late biopsies did not show C4d deposition, and the patient had low serum DSA levels, raising the possibility that noncomplement-mediated pathways may be involved in late antibody-mediated allograft injury. The pathologist can recognize changes attributable to alloantibody and distinguish these features from T-cell-mediated rejection, which will allow for appropriate treatment of these patients.

AB - Antibody-mediated renal allograft injury can give rise to a range of histological and ultrastructural changes, with or without C4d deposition. The changes associated with alloantibody can be seen on surveillance biopsies in patients with normal graft function or on clinically indicated biopsies. In this case report, we review a series of biopsies at different time points, from 1 month to 2 years after transplantation, from a single kidney allograft in a patient who had donor-specific alloantibody (DSA) before transplantation. In the early posttransplant period, the patient was at risk for acute humoral rejection, with high serum DSA levels and C4d deposition in the graft, but acute humoral rejection was averted by early use of a C5 inhibitor drug. Later, while maintaining stable graft function, the patient developed the following biopsy features of chronic antibody-mediated injury: peritubular capillaritis, peritubular capillaropathy (peritubular capillary basement membrane multilamination) seen by electron microscopy, and early transplant glomerulopathy, along with activated endothelial cells detected by electron microscopy. Late biopsies did not show C4d deposition, and the patient had low serum DSA levels, raising the possibility that noncomplement-mediated pathways may be involved in late antibody-mediated allograft injury. The pathologist can recognize changes attributable to alloantibody and distinguish these features from T-cell-mediated rejection, which will allow for appropriate treatment of these patients.

KW - eculizumab

KW - kidney

KW - peritubular capillary

KW - sensitized

KW - transplant

UR - http://www.scopus.com/inward/record.url?scp=84869813175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84869813175&partnerID=8YFLogxK

U2 - 10.1097/PCR.0b013e3182759333

DO - 10.1097/PCR.0b013e3182759333

M3 - Article

VL - 17

SP - 219

EP - 224

JO - Pathology Case Reviews

JF - Pathology Case Reviews

SN - 1082-9784

IS - 6

ER -